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NTRODUCTION
The healing of cutaneous wounds is a complex process that
requires the integration of biological and molecular events
such as cell migration and proliferation, extracellular matrix
(ECM) deposition, angiogenesis, and remodeling (1). How-
ever, this orderly progression is impaired in many chronic
diseases, such as, diabetes (2). During the past two decades,
substantial progress has been made with respect to our under-
standing of the pathophysiology of wound healing; and new
therapeutic methods have been developed. However, enhance-
ment of wound healing remains a common challenge in the
fields of plastic and reconstructive surgery.
Adipose-derived stromal cells (ADSCs) are abundant in
fatty tissue, and are also referred to stromal vascular fraction
(SVF), processed lipoaspirate cells (PLA), and adipose tissue-
derived stem cells (ATSCs). In addition, ADSCs have multi-
lineage mesodermal potential like bone marrow mesenchy-
mal stem cells (BMSCs) (3, 4). ADSCs and BMSCs have been
studied in various fields with respect to the effect on wound
healing and their clinical applications (3-5). Wu et al. (6)
reported that BMSCs enhance wound healing, whereas Kim
et al. (7) reported that ADSCs also promote wound healing. 
In this study, we examined effects of ADSCs applied in
wound healing splint model (8), and determinated whether
factors present in cell extracts of ADSCs enhanced wound
healing. 
MATERIALS AND METHODS
Animal care 
All protocols were approved by the Institutional Animal
Care and Use Committee in Songeui Campus, The Catholic
University of Korea (CUMC-2008-0155-01). All animals
were treated in compliance with the National Research Coun-
cil criteria as outlined in the ‘‘Guide for the Care of Laborato-
ry Animals’’ prepared by the Institute of Laboratory Animal
Resources and published by the National Institute of Health. 
Isolation of adipose-derived stem cells 
Epididymal fat pads of six 8-weeks male BALB/c mice
were obtained and washed with phosphate buffer saline (PBS;
Sigma Chemical Co, St. Louis, MO, USA) with 100 units/mL
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Effects of Adipose-derived Stromal Cells and of their Extract 
on Wound Healing in a Mouse Model
In this study, the authors investigated the effects of adipose-derived stromal cells
(ADSCs) and of their extract on wound healing. After creating wound healing splint
model on the backs of mice, ADSCs and their extract were applied. Wound healing
rates were calculated at 3, 5, 7, 10, and 14 days after the wounding, and tissues
were harvested at 7 and 14 days for histological analysis. Wound healing rates were
significantly higher at 7, 10, and 14 days in the cell group than in the control, but in
the cell extract group wound healing rates were significantly decreased (P<0.05).
Histological scores and capillary densities in the cell group were significantly higher
at 2 weeks (P<0.05). In the cell group, thick inflammatory cell infiltration and many
capillaries were observed at 1 week, and thick epithelium and numerous large cap-
illaries were observed at 2 weeks. The present study suggests that ADSCs accel-
erate wound healing as known, and the effects of ADSCs on wound healing may
be due to replacing insufficient cells by differentiation of ADSCs in the wound and
secreting growth factors by differentiated cells, and not due to the effect of factors
within ADSCs.
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penicillin and 100 units/mL streptomycin (Gibco BRL, Grand
Island, NY, USA). After mincing the fat pads, the minced fat
tissue was digested at 37℃for 1 hr with intermittent shak-
ing in PBS with 0.03% collagenase (Sigma) and neutralized
with same amount of basic media (Dulbecco’s Modified Eagle’s
Media high glucose [DMEM-hg]; Gibco) containing 10%
fetal bovine serum (FBS; Gibco), 100 units/mL penicillin and
100 units/mL streptomycin (Gibco). After filtration through
a 25-mm filter and centrifugation (250 g, 10 min), the float-
ing fat and adipocytes were removed. The cells in precipitated
layer were cultured in basic media in humidified air with 5%
(v/v) CO2 at 37℃. The non-adherent cells were washed with
PBS after 24 hr and the media was changed every 3 days.
Before the cells were confluent, the cells were subcultured
after isolation with 0.25% trypsin-EDTA (Gibco). The cells
thus obtained were regarded as ADSCs, which were used for
the experiments at passages 1-5.
Wound healing model and ADSCs transplantation
The experimental mice were randomly divided into three
groups and the excisional splinting model was generated as
described previously (8). In brief, after hair removal from the
dorsal surface and anesthesia, two 6-mm full thickness exci-
sional skin wounds were created on each side of the midline.
For control group (n=8), 60 mL of PBS was injected intrader-
mally around the wound at four injection sites and 40 mL of
PBS was applied onto the wound bed. For cell group (n=8),
60 mL of PBS containing 0.6 mL×106 cells was injected intra-
dermally around the wound at four injection sites. PBS (40
mL) containing 0.4×106 cells was also applied onto the wound
bed. For cell extract group (n=8), after 100 mL of PBS contain-
ing 1×106 cells was frozen and thawed rapidly three times,
60 mL was injected intradermally around the wound at four
injection sites and 40 mL was applied onto the wound bed.
A donut shaped silicone splint was placed so that the wound
was centered within the splint. An immediate-bonding adhe-
sive (Krazy Glue
�; Elmer’s Inc., Columbus, OH, USA) was
used to fix the splint to the skin, followed by interrupted
sutures to stabilize its position and Tegaderm (3M Health
Care, 3M, St. Paul, MN, USA) was placed over the wounds
(Fig. 1). The animals were housed individually. We tested
the adhesive on the skin in mice prior to this experiment and
did not find any skin irritation or allergic reaction. 
Wound analysis
Digital photographs of wounds were taken at days 3, 5, 7,
10, and 14. Time to wound closure was defined as the time
at which the wound bed was completely re-epithelialized and
filled with new tissue. Wound area was measured by tracing
the wound margin and calculated using an image analysis pro-
gram (Image J; National Institute of Health, Bethesda, MD,
USA). The investigators who measured the wound were blind-
ed. The wound healing rate was calculated as follows: (Area
of original wound-Area of remaining wound)/Area of origi-
nal wound ×100. 
Histological examination 
Mice were sacrificed at 7 and 14 days, when skin samples
including the wound and 5 mm surrounding skin, were har-
vested. The specimens were fixed in 10% neutral buffered
formalin for at least 25 hr at room temperature. After fixa-
tion, perpendicular sections to the anterior-posterior axis of
the wound were embedded in paraffin. Five mm-thick sections
were stained with hematoxylin and eosin. As part of the his-
tological evaluation, all slides were examined in blind fashion
under ×40 to ×100 magnifications. Each slide was given
a histological score ranging from 1 to 12: 1-3, none to min-
imal cell accumulation, no granulation tissue or epithelial
travel; 4-6, thin, immature granulation, dominated by inflam-
matory cells with a few fibroblasts, capillaries, or collagen
deposition, and minimal epithelial migration; 7-9, moder-
ately thick granulation tissue, dominant inflammatory cells,
more fibroblasts and collagen deposition, extensive neovas-
cularization, and minimal to moderate migrating epithelium;
10-12, thick, vascular granulation tissue dominated by fibrob-
lasts and extensive collagen deposition, and epithelium par-
tially to completely covering the wound (9).
Immunohistochemical examination 
Five mm-thick sections were placed on Superfrost/Plus
slides (Fisher Scientific, Pittsburgh, PA, USA). The sections
were defaraffinized, rehydrated through graded alcohols, pre-
treated with 3% hydrogen peroxide in PBS for 15 min to
block endogenous peroxidase activity, and then blocked for
non-specific protein binding with 3% rabbit serum (Sigma)
in PBS. Primary rat anti-mouse CD31 antibodies (platelet
endothelial cell adhesion molecule-1 [PECAM-1], BD Phar-
Fig. 1. Two 6-mm circular full-thickness skin defects on the back
of mouse with silicone rings.748 J.S. Lim and G. Yoo
mingenTM, San Diego, CA, USA) are diluted 1:50 in PBS
and applied on the sections. The slides were incubated with
the antibody overnight at 4℃ in a humid chamber. After
three washes with PBS for 3 min each, sections were flooded
and incubated for 40 min at 36℃ with anti-rat IgG-peroxi-
dase (Sigma) diluted 1 in 500 in PBS. The slides were washed
in PBS. Then, the detected antigens were visualized by incu-
bation with 3,3′ -diaminobenzidine tetra-hydrochloride solu-
tion (DAB peroxidase substrate, Sigma). Finally, sections were
counterstained with Mayers hematoxylin and mounted.
Capillary density was assessed morphometrically by exam-
ining three fields per section of the wound between the edges
in six successive sections after immunofluorescence staining
for endothelial cells with anti-CD31 antibody. Capillaries,
identified by positive staining for CD31 and appropriate mor-
phology, were counted by a single observer in blind fashion
under ×400 magnification. Capillary density was calculated
as mean number of capillaries per high power field (HPF) (10). 
Statistical analysis
All results were expressed as mean±SEM. Statistical anal-
ysis was performed with ANOVA followed by Duncan’s new
Multiple Range Test using SPSS for Windows (Version 15.0).
P values <0.05 were considered to denote statistical signifi-
cance.
RESULTS
Wound healing rates
Wound healing rates were measured at 3, 5, 7, 10, and
14 days after the wounding. The rates were 29.7±9.5%,
32.2±9.3%, 45.6±16.4%, 61.0±19.1%, and 89.6±
6.6%, respectively, in the control group; 13.8±10.3%, 28.6
±15.3%, 57.7±18.6%, 80.1±5.8%, and 98.3±2.5%
in the cell group; and 10.0±4.0%, 16.2±10.2%, 22.4±
20.6%, 53.8±28.5%, and 92.0±4.2% in the cell extract
group, respectively. In all groups, wound healing rates in-
creased with time. Wound healing rates in the two experi-
mental groups were significantly lower than in the control
group at 3 days after wounding, but were significantly high-
er at 7, 10, and 14 days after wounding (P<0.05). 
In the cell extract group, wound healing rates were signifi-
cantly lower at 3, 5, and 7 days after the wounding and were
not significantly different from those of the control at 10 days.
Furthermore, wound healing rates were lower in the cell extract
group than in the cell group from 5 days after wounding (P<
0.05) (Fig. 2).
Histology and immunohistochemistry 
The histological scores of wounds were 3.3±0.6 (control
group), 4.5±0.7 (cell group), and 3.1±0.6 (cell extract
group) at 1 week after the wounding and 5.2±0.8 (control
group), 8.0±1.9 (cell group), and 6.2±0.9 (cell extract
group) at 2 weeks. The cell group had significantly higher
scores than the other two groups at 1 and 2 weeks after wound-
ing (P<0.05), and no significant difference was observed bet-
ween the control and cell extract groups (Fig. 3).
Histological evaluation of week 1 and 2 wounds disclosed
that the cell group had enhanced cellularity (Fig. 4) and in-
creased vasculature (also shown in Fig. 5). Granulation tissue
in the cell group appeared to be thicker and larger than other
groups (Fig. 4). In addition, the cell group wounds appeared
to have increased reepithelialization. However, in the cell
extract group, celluarity and granulation tissue were similar
to those of the control at 1 and 2 weeks after wounding (Fig.
4), and decreased vascularity (also shown in Fig. 5).
Mean capillary densities were 9.0±3.6/HPF (control group),
9.8±2.4/HPF (cell group), and 9.3±6.2/HPF (cell extract
group) at 1 week, and there was no significant difference bet-
ween the groups. At 2 weeks, mean capillary densities were
*
Fig. 2. Changes of wound healing rates of the control, the cell, and
the cell extract groups at 3, 5, 7, 10, and 14 days after wounding. 
*P<0.05 compared to control; 
� P<0.05 compared to the cell group;
� P<0.05 compared to the cell extract group.
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Fig. 3. Histological scores of wound in the control, the cell group,
and the cell extract groups at 1 and 2 weeks after wounding. 
*P<0.05 compared to control and the cell extract group.
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17.3±3.0/HPF (control group), 24.5±6.7/HPF (cell group),
and 19.1±4.9/HPF (cell extract group) and all groups show-
ed higher capillary densities than those at 1 week after the
wounding. In particular, capillary density was significantly
Fig. 4. Micrographs of wound bed and wound margin in each group at 1 and 2 weeks after wounding (H&E stain, 40). Wound edges are
indicated by arrows. At 1 week after wounding, the control group shows thin granulation tissue containing many neutrophils and lympho-
cytes (A), the cell group shows thick inflammatory cell infiltrations with many capillaries (B), and the cell extract group has more granula-
tion tissues than in the control group (C). At 2 weeks after wounding, the control group shows thick granulation tissues with little re-epithe-
lialization (D), the cell group shows slightly thicker epithelium and greater granulation tissue (E), and the cell extract group shows less re-
epithelization and granulation tissue than in the cell group at 2 weeks (F).
1 week
A B C
2 weeks
D E F
Control Cell group Cell extract group
Fig. 5. Micrographs of wound bed and wound margin in each group at 1 and 2 weeks after wounding (Immunohistochemical staining for
CD31, ×100). Capillaries with endothelial cells are stained brown (thin arrows). Wound edges are indicated by thick arrows. At 1 week, some
small numbers of capillaries are observed in granulation tissues in the control group (A) and the cell extract group (C), but large numbers
of capillaries are observed in the cell group (B). At 2 weeks after wounding, increased capillary development is noted in the control group
(D), the cell group (E), and the cell extract groups (F). Particularly, in the cell group numerous larger capillaries are observed in compari-
son with other groups.
1 week
A B C
2 weeks
D E F
Control Cell group Cell extract group750 J.S. Lim and G. Yoo
higher in the cell group than those in the other groups at 2
weeks (P<0.05) (Fig. 6).
DISCUSSION
Cutaneous wound healing process requires interactions bet-
ween cells in the dermis and epidermis and the release of chem-
ical mediators from inflammatory cells, fibroblasts, and ker-
atinocytes. The proliferation of mesenchymal cells and cap-
illaries, as well as the influx of macrophages into granulation
tissue, serves to replace the dermal defect and to provide sub-
strates and inducers for re-epithelialization. Because various
cell types participate in wound healing process, various cell-
based therapies offer promising therapeutic strategies to im-
prove wound healing in physiological and pathological con-
ditions. In recent studies, the transplantation of BMSCs has
been reported to activate the healing process due to their capac-
ity to differentiate in the skin epidermis and appendages, thus
to mediate dermal regeneration (6). And also several studies
have recently demonstrated accelerated rates of wound closure
after transplantations of BMSCs (11), mesenchymal stem cells
(12), or ADSCs (7). In our experiments, the ADSC-treated
group showed significantly more rapid wound healing rates
and had higher histological scores than those of the control
group. Authors used the wound healing splint model, which
is invented to prevent skin contraction around the wound,
allow the wounds to heal via granulation and re-epithelial-
ization (8). Acceleration of wound healing rates by ADSCs
treatment in this model is thought to be caused by the sub-
stitution of deficient cells after differentiation of ADSCs as
stated in previous reports (6).
Neovascularization is a crucial step in wound healing pro-
cess (2), which is necessary to sustain newly formed granula-
tion tissue and ensure the survival of keratinocytes. Wu et al.
(6) demonstrated that BMSC-treated wounds have higher
capillary densities, and suggested that BMSCs promote angio-
genesis. In our study, ADSC-treated wounds had significantly
higher capillary densities than that of the control group, which
suggestd that ADSCs, like BMSCs, promote neovasculari-
zation. The promoting neovascualrization by ADSCs is con-
sidered one of factors which accelerate the wound healing by
ADSCs.
Many types of cytokines and growth factors are responsible
for inflammation, re-epithelialization, the formation of gran-
ulation tissue, and neovascularization during the healing pro-
cess. Thus the application or induction of these cytokines and
factors is known to accelerate wound healing (13). Kim et al.
(7) reported that paracrine factors secreted by ADSCs induce
collagen synthesis and promote wound healing through fibrob-
last activation, migration, and proliferation. Gaustad et al.
also reported that cell extracts, which contain growth and dif-
ferentiation factors, can be used as an alternative to stimulate
surface molecules to promote the differentiation of ADSCs
to target cells (14). Cell extract was thought to differentiate
mesenchymal stem cells, which are located in tissues around
wound, into cells required for the wound healing process. In
order to confirm the note of cell extract, we performed this
comparative study on the effect of ADSCs and ADSC cell
extract on wound healing to investigate whether cell extract
from ADSCs could have beneficiary effect on wound healing.
Our results showed that the cell extract group showed rather
lower wound healing rates than those of the control group
throughout experimental periods, and no significant differ-
ence versus the control until 2 weeks. Because ADSCs are
not differentiated cells, the promotion of the specific differ-
entiation of mesenchymal stem cells by cell extract of ADSCs
would not occur. This result was in contrast to a previous
report (14). Accordingly, we consider that ADSC cell ext-
ract has no effect on wound healing, and that many factors
in ADSC cell extract are less helpful in wound healing. 
In conclusion, our experiments showed that ADSCs treat-
ment enhanced wound healing as previously reported. Fur-
thermore, our results suggest that this beneficiary effects of
ADSCs on wound healing may be not caused by factors in
ADSCs, but rather by the substitution of deficient cells after
differentiation of ADSCs.
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